The Resistance of Cervical Cancer to Chemotherapy and its Reversal
Academic Press Inc (Verlag)
978-0-443-22352-5 (ISBN)
- Noch nicht erschienen (ca. Februar 2026)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.
Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. He is also involved in the identifying the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) and serving as Associate Professor and Head at Cancer Research Centre working in the area of development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.
1. Wnt signalling and cervical cancer
2. Pharmacologial targets of cervical cancer
3. PD-1, HPV and cervical cancer
4. Radiotherapy and cervical cancer
5. HPV and cervical cancer
6. EGFR and cervical cancer
7. Protein engineering for cervical cancer
8. Anti-virals and cervical cancer
9. Advances in cytological screening for cervical cancer
10. microRNA and cervical cancer
11. Computer aided drug designing for cervical cancer
12. Nanoparticles for the treatment of cervical cancer
| Erscheint lt. Verlag | 2.2.2026 |
|---|---|
| Reihe/Serie | Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy |
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 191 x 235 mm |
| Gewicht | 450 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Naturwissenschaften ► Biologie | |
| ISBN-10 | 0-443-22352-1 / 0443223521 |
| ISBN-13 | 978-0-443-22352-5 / 9780443223525 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
